Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children.

Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children.

Item
http://www.wikidata.org/entity/Q34544211
A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study.New approaches in the management of chronic hepatitis B: role of tenofovir.Commentary: The place of tenofovir disoproxil fumarate in pediatric antiretroviral therapy.Steady-state pharmacokinetics of tenofovir-based regimens in HIV-infected pediatric patients.The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment.Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection.Colorectal delivery and retention of PEG-Amprenavir-Bac7 nanoconjugates--proof of concept for HIV mucosal pre-exposure prophylaxis.Age-related differences in plasma and intracellular tenofovir concentrations in HIV-1-infected children, adolescents and adultsDecreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus.Efavirenz/emtricitabine/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all?Pediatric antiretroviral therapy.Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges.Impact of disease, drug and patient adherence on the effectiveness of antiviral therapy in pediatric HIV.PENTA guidelines for the use of antiretroviral therapy, 2004.Adverse effects of tenofovir use in HIV-infected pregnant women and their infants.
P2860

Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children.

Item
http://www.wikidata.org/entity/Q34544211
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Single-dose and steady-state p ...... iency virus-infected children.
@ast
Single-dose and steady-state p ...... iency virus-infected children.
@en
Single-dose and steady-state p ...... iency virus-infected children.
@nl
type
label
Single-dose and steady-state p ...... iency virus-infected children.
@ast
Single-dose and steady-state p ...... iency virus-infected children.
@en
Single-dose and steady-state p ...... iency virus-infected children.
@nl
prefLabel
Single-dose and steady-state p ...... iency virus-infected children.
@ast
Single-dose and steady-state p ...... iency virus-infected children.
@en
Single-dose and steady-state p ...... iency virus-infected children.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Single-dose and steady-state p ...... iency virus-infected children.
@en
P2093
P2860
P304
P31
P356
10.1128/AAC.48.1.124-129.2004
P407
P433
P478
P50
P577
P698
P932